Development of a Model to Predict the Risk of Venous Thromboembolic Events in Patients With Metastatic Bronchopulmonary Cancer (LUCAAT)

Regional University Hospital Center (CHRU)

Status: Unknown

Conditions: Metastatic Bronchopulmonary Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT04196790

LUCAAT ( 29BRC19. 0224)

Details and patient eligibility

About

Venous thrombo-embolism (VTE) is a frequent and serious complication of cancer. However, predictive tools for VTE in cancer patients is lacking.

In patients with metastatic broncho-pulmonarycancer, biochemical characteristics might help to identify patients at high risk for VTE.

The aim of this study is to derive a predictive score combining clinical and biochemical variable that predict VTE in metastatic broncho-pulmonary cancer.

Full description

Venous thrombo-embolism (VTE) is a frequent and serious complication of cancer. However, predictive tools for VTE in cancer patients is lacking.

In patients with metastatic broncho-pulmonarycancer, biochemical characteristics might help to identify patients at high risk for VTE, particularly in adenocarcinoma.

The aim of this study is to derive a predictive score combining clinical and biochemical variable that predict VTE in metastatic broncho-pulmonary cancer.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• metastatic broncho-pulmonary cancer
• age ≥18 years
• who are eligible for chemotherapy
• non opposition obtained

Exclusion criteria

• age <18 years
• pregnancy, breast feeding
• VTE in the past 6 months or at the time of cancer diagnosis
• surgery in the past 3 months
• refusal to participate